Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | PPIA | P62937 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28252892 | 0.98 | ALDH1A1 (0.47) | ALDH1A1ALOX15PPIAPOLBL3MBTL1 | |
| SCHEMBL28252208 | 0.82 | TSHR (0.46) | ALDH1A1POLBL3MBTL1LMNATSHR | |
| SCHEMBL31000747 | 0.82 | PPIA (0.45) | ALDH1A1ALOX15PPIAPOLBL3MBTL1 | |
| SCHEMBL6276445 | 0.82 | PPIA (0.45) | ALDH1A1ALOX15PPIAPOLBL3MBTL1 | |
| SCHEMBL2913776 | 0.82 | ALDH1A1 (0.45) | ALDH1A1ALOX15PPIAPOLBL3MBTL1 | |
| SCHEMBL6918557 | 0.81 | KDM4E (0.47) | ALDH1A1PPIAPOLBL3MBTL1LMNA | |
| SCHEMBL6913171 | 0.81 | KDM4E (0.47) | ALDH1A1PPIAPOLBL3MBTL1LMNA | |
| SCHEMBL6914993 | 0.81 | KDM4E (0.47) | ALDH1A1PPIAPOLBL3MBTL1LMNA | |
| SCHEMBL6918561 | 0.81 | KDM4E (0.47) | ALDH1A1PPIAPOLBL3MBTL1LMNA | |
| Zinc Ion SCHEMBL6913390 | 0.81 | KDM4E (0.47) | ALDH1A1PPIAPOLBL3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 274 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120020115-A | Process for the preparation of N- (alkyl-2-hydroxy) alkylamides and N-alkenylamides | 中国石油化工股份有限公司 | 2025-05-20 | — | — | CN | claimed |
| CN-120020114-A | Preparation method of N-alkenyl amide compound | 中国石油化工股份有限公司 | 2025-05-20 | — | — | CN | claimed |
| CN-114773606-B | Preparation method of selenium-containing hyperbranched polymer with ester bond as core | 湖北宜化新材料科技有限公司 | 2023-03-31 | — | — | CN | claimed |
| CN-114773606-A | Preparation method of selenium-containing hyperbranched polymer with ester bond as core | 湖北宜化新材料科技有限公司 | 2022-07-22 | — | — | CN | claimed |
| CN-108779140-B | Compounds and methods for synthesizing 5- (N-protected tryptophanyl carboxamide) -2' -deoxyuridine phosphoramidites for incorporation into nucleic acid sequences | 私募蛋白质体操作有限公司 | 2022-04-12 | — | — | CN | claimed |
| US-10634679-B2 | Compounds and methods for the synthesis of 5-(N-protected-tryptaminocarboxyamide)-2′-deoxyuridine phosphoramidite for incorporation into a nucleic acid | SOMALOGIC, INC. (US) | 2020-04-28 | — | — | US | claimed |
| EP-3430022-B1 | COMPOUNDS AND METHODS FOR THE SYNTHESIS OF 5-(N-PROTECTED-TRYPTAMINOCARBOXYAMIDE)-2'-DEOXYURIDINE PHOSPHORAMIDITE FOR INCORPORATION INTO A NUCLEIC ACID SEQUENCE | SOMALOGIC INC (US) | 2020-03-11 | — | — | EP | claimed |
| CN-110256993-A | It is a kind of applied to the colloid copper foil for preparing copper coated foil plate | 广东嘉元科技股份有限公司 | 2019-09-20 | — | — | CN | claimed |
| CN-109591426-A | Preparation device of copper-clad plate and colloidal copper foil applied to preparation of copper-clad plate | 广东嘉元科技股份有限公司 | 2019-04-09 | — | — | CN | claimed |
| US-20190031702-A1 | Compounds and Methods for the Synthesis of 5-(N-Protected-Tryptaminocarboxyamide)-2'-Deoxyuridine Phosphoramidate for Incorporation into a Nucleic Sequence | SOMALOGIC, INC. (US) | 2019-01-31 | — | — | US | claimed |
| US-7071341-B2 | α-Glucosidase inhibitors and their synthesis from a natural source | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2006-07-04 | — | — | US | claimed |
| EP-1572675-A1 | NEW ALPHA-GLUCOSIDASE INHIBITORS AND THEIR SYNTHESIS FROM A NATURAL SOURCE | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-09-14 | — | — | EP | claimed |
| EP-1514866-A1 | Process for producing cyanobenzoic acid derivatives | SHOWA DENKO KABUSHIKI KAISHA (JP) | 2005-03-16 | — | — | EP | claimed |
| US-20040171674-A1 | Alpha-glucosidase inhibitors and their synthesis from a natural source | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEA | 2004-09-02 | — | — | US | claimed |
| WO-2004054995-A1 | NEW ALPHA-GLUCOSIDASE INHIBITORS AND THEIR SYNTHESIS FROM A NATURAL SOURCE | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2004-07-01 | — | — | WO | claimed |
| CN-1316988-A | Process for preparing cyanophenyl derivatives | SHOWA DENKO KK (JP) | 2001-10-10 | — | — | CN | claimed |
| EP-0989115-A2 | Process for producing cyanobenzoic acid derivatives | Showa Denko Kabushiki Kaisha (JP) | 2000-03-29 | — | — | EP | claimed |
| WO-1993014055-A1 | PREPARATION OF 2,5-DICHLOROBENZOPHENONES | MAXDEM INCORPORATED (US) | 1993-07-22 | — | — | WO | claimed |
| US-5210313-A | Friedel crafts aryloylation of 1,4-dichlorobenzene and Lewis acids | MAXDEM INCORPORATED (US) | 1993-05-11 | — | — | US | claimed |
| US-4709054-A | REACTION OF AROMATIC ACYL HALIDE AND HALOGENATED POLYSILANE, TRANSITION METAL CATALYST | GENERAL ELECTRIC COMPANY (US) | 1987-11-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171674-A1 | Alpha-glucosidase inhibitors and their synthesis from a natural source | GANAB, GAA, GBA3 | ALDH1A1 1774/4885ALOX15 4722/4885PPIA 2046/4885 |
| US-10634679-B2 | Compounds and methods for the synthesis of 5-(N-protected-tryptaminocarboxyamide)-2′-deoxyuridine phosphoramidite for incorporation into a nucleic acid | DUT, TYMP, HNMT | ALDH1A1 3348/4885ALOX15 1705/4885PPIA 3546/4885 |
| US-20190031702-A1 | Compounds and Methods for the Synthesis of 5-(N-Protected-Tryptaminocarboxyamide)-2'-Deoxyuridine Phosphoramidate for Incorporation into a Nucleic Sequence | TYMP, TYMS, NT5C2 | ALDH1A1 4052/4885ALOX15 1753/4885PPIA 3213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.